基于peg-344基因的CRKP感染预后列线图预测模型的构建与验证
Construction and Validation of a Prognostic Nomogram for Carbapenem-Resistant Klebsiella pneumoniae Infection Based on the peg-344 Gene
DOI: 10.12677/acm.2025.15123594, PDF,    科研立项经费支持
作者: 王秋妍, 滕 宣, 闫 涛, 马成成, 余可雪:安徽省胸科医院临床检验中心,安徽 合肥;安徽医科大学第二附属医院检验科,安徽 合肥;刘 周*:安徽省胸科医院临床检验中心,安徽 合肥
关键词: 碳青霉烯耐药肺炎克雷伯菌peg-344基因预后不良危险因素Carbapenem Resistance Klebsiella pneumoniae peg-344 Gene Poor Prognosis Risk Factors
摘要: 目的:探索碳青霉烯类耐药肺炎克雷伯菌(carbapenem-resistant Klebsiella pneumoniae, CRKP)感染患者临床结局的影响因素,并构建列线图预测模型。方法 收集安徽省某三甲医院2020年8月至2024年8月内所有的CRKP感染病例,以8:2的比例随机拆分为训练集(122例)和验证集(31例),根据患者临床结局将训练集和验证集分为预后良好组和预后不良组,使用Logistic回归分析得到关联强度较高的危险因素,将其纳入多因素逻辑回归分析,并构建风险预测列线图,利用受试者工作特征(Receiver Operating Characteristic, ROC)曲线、校准曲线评估预测模型对住院患者CRKP感染临床结局的预测效能。结果:分析显示神经系统疾病、入住重症监护室、败血症或休克以及CRKP菌株peg-344基因阳性携带为CRKP感染患者预后不良的独立影响因素,分析得到相应的列线图模型。模型的训练集ROC曲线下面积(Area Under the Curve, AUC)为0.770 (95%CI: 0.687~0.854),验证集ROC曲线下面积为0.717 (95%CI: 0.527~0.907),校准曲线显示模型校准度良好。结论:根据模型评估及图表数据,该CRKP感染患者预后的列线图预测模型具有较好的检验效能及拟合优度,可有效预测CRKP感染患者出现不良预后的风险,有助于尽早采取相关临床干预措施。
Abstract: Objective: To explore the factors influencing the clinical outcomes of patients infected with carbapenem-resistant Klebsiella pneumoniae (CRKP) and to construct a nomogram prediction model. Methods: We collected all CRKP infection cases from a tertiary hospital in Anhui Province from August 2020 to August 2024. The cases were randomly split into a training set (122 cases) and a validation set (31 cases) in an 8:2 ratio. Based on the clinical outcomes of the patients, the training and validation sets were divided into good and poor prognosis groups. Logistic regression analysis was used to identify risk factors with high association strength, which were then included in a multivariate logistic regression analysis to construct a risk prediction nomogram. The prediction model’s performance in predicting the clinical outcomes of CRKP infections in hospitalized patients was assessed using receiver operating characteristic (ROC) curves and calibration curves. Results: The analysis revealed that neurological diseases, admission to the intensive care unit, sepsis or shock, and the presence of the peg-344 gene in CRKP strains were independent factors associated with poor prognosis in CRKP-infected patients. The corresponding nomogram model was developed. The area under the ROC curve (AUC) for the training set was 0.770 (95%CI: 0.687~0.854), and for the validation set, it was 0.717 (95%CI: 0.527~0.907). The calibration curve showed good model calibration. Conclusion: Based on model evaluation and graphical data, the nomogram prediction model for CRKP infection prognosis demonstrated good discrimination and calibration, effectively predicting the risk of poor outcomes in CRKP-infected patients and aiding in the early implementation of relevant clinical interventions.
文章引用:王秋妍, 滕宣, 闫涛, 马成成, 余可雪, 刘周. 基于peg-344基因的CRKP感染预后列线图预测模型的构建与验证[J]. 临床医学进展, 2025, 15(12): 1783-1793. https://doi.org/10.12677/acm.2025.15123594

参考文献

[1] 熊琴, 王震宇, 宋涛. 耐碳青霉烯类肺炎克雷伯菌感染风险预测模型的构建[J]. 检验医学与临床, 2023, 20(6): 771-775.
[2] Hu, F., Pan, Y., Li, H., Han, R., Liu, X., Ma, R., et al. (2024) Carbapenem-Resistant Klebsiella pneumoniae Capsular Types, Antibiotic Resistance and Virulence Factors in China: A Longitudinal, Multi-Centre Study. Nature Microbiology, 9, 814-829. [Google Scholar] [CrossRef] [PubMed]
[3] 莫银竹, 程贤雄, 宋沧桑, 等. 耐碳青霉烯类肺炎克雷伯菌感染风险预测模型的构建及验证[J]. 中国药房, 2025, 36(14): 1786-1791.
[4] Wang, M., Earley, M., Chen, L., Hanson, B.M., Yu, Y., Liu, Z., et al. (2022) Clinical Outcomes and Bacterial Characteristics of Carbapenem-Resistant Klebsiella pneumoniae Complex among Patients from Different Global Regions (CRACKLE-2): A Prospective, Multicentre, Cohort Study. The Lancet Infectious Diseases, 22, 401-412. [Google Scholar] [CrossRef] [PubMed]
[5] 薛娟, 谢敏, 周婷. 耐碳青霉烯类肺炎克雷伯菌感染患者的全因死亡率分析[J]. 中国临床药理学杂志, 2018, 34(18): 2220-2223.
[6] 张慧, 陈怡昕, 郭莉媛. 术前LAR预测上皮性卵巢癌患者预后的价值及预后列线图模型的构建与评价[J]. 现代肿瘤医学, 2025, 33(7): 1190-1198.
[7] Mei, Z., Chen, J., Chen, P., Luo, S., Jin, L. and Zhou, L. (2022) A Nomogram to Predict Hyperkalemia in Patients with Hemodialysis: A Retrospective Cohort Study. BMC Nephrology, 23, Article No. 351. [Google Scholar] [CrossRef] [PubMed]
[8] 滕双芩, 匡竞, 申彤彤, 等. 耐碳青霉烯类肺炎克雷伯菌感染风险预测模型的构建与验证[J]. 中国呼吸与危重监护杂志, 2024, 23(11): 761-768.
[9] 范帅华, 吴圣, 林金兰, 等. 多重耐药肺炎克雷伯杆菌院内感染患者预后预测列线图模型的构建及验证[J]. 中国临床研究, 2023, 36(7): 1033-1037.
[10] 刘小婷, 杨欢, 姚红, 等. 碳青霉烯类耐药肺炎克雷伯菌感染死亡风险预测模型的建立及其对患者预后的预测价值研究[J]. 中国全科医学, 2020, 23(30): 3789-3797.
[11] Chu, X., Ning, L., Fang, Y., Jia, H. and Wang, M. (2024) Risk Factors and Predictive Nomogram for Carbapenem-Resistant Klebsiella pneumoniae in Children in a Grade 3 First-Class General Hospital in Central China. Infection and Drug Resistance, 17, 41-49. [Google Scholar] [CrossRef] [PubMed]
[12] Lu, G., Zhang, J., Shi, T., Liu, Y., Gao, X., Zeng, Q., et al. (2024) Development and Application of a Nomogram Model for the Prediction of Carbapenem-Resistant Klebsiella pneumoniae Infection in Neuro-ICU Patients. Microbiology Spectrum, 12, e0309623. [Google Scholar] [CrossRef] [PubMed]
[13] Qian, Y., Bi, Y., Liu, S., Li, X., Dong, S. and Ju, M. (2021) Predictors of Mortality in Patients with Carbapenem-Resistant Klebsiella pneumoniae Infection: A Meta-Analysis and a Systematic Review. Annals of Palliative Medicine, 10, 7340-7350. [Google Scholar] [CrossRef] [PubMed]
[14] Chen, J., Ma, H., Huang, X., Cui, Y., Peng, W., Zhu, F., et al. (2022) Risk Factors and Mortality of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection in a Tertiary-Care Hospital in China: An Eight-Year Retrospective Study. Antimicrobial Resistance & Infection Control, 11, Article No. 161. [Google Scholar] [CrossRef] [PubMed]
[15] 张迪, 张春丽, 牛雷, 等. PBS评分、SOFA评分、CCI指数及D-D、ALB预测CRKP血流感染患者死亡的价值及耐药性分析[J]. 检验医学与临床, 2021, 18(16): 2408-2411.
[16] Baecher-Allan, C., Kaskow, B.J. and Weiner, H.L. (2018) Multiple Sclerosis: Mechanisms and Immunotherapy. Neuron, 97, 742-768. [Google Scholar] [CrossRef] [PubMed]
[17] Singh, D. (2022) Astrocytic and Microglial Cells as the Modulators of Neuroinflammation in Alzheimer’s Disease. Journal of Neuroinflammation, 19, Article No. 206. [Google Scholar] [CrossRef] [PubMed]
[18] 张嫘, 耿荣华, 蔡珍, 等. 中枢神经系统感染患者的临床及病原学特征研究[J]. 中国抗生素杂志, 2022, 47(4): 393-398.
[19] 岳彩妮. 肺炎克雷伯菌感染的临床特征及碳青霉烯类耐药死亡的危险因素[D]: [硕士学位论文]. 合肥: 安徽医科大学, 2022.
[20] Pu, D., Zhao, J., Chang, K., Zhuo, X. and Cao, B. (2023) “Superbugs” with Hypervirulence and Carbapenem Resistance in Klebsiella pneumoniae: The Rise of Such Emerging Nosocomial Pathogens in China. Science Bulletin, 68, 2658-2670. [Google Scholar] [CrossRef] [PubMed]
[21] Zhou, K., Xiao, T., David, S., Wang, Q., Zhou, Y., Guo, L., et al. (2020) Novel Subclone of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 11 with Enhanced Virulence and Transmissibility, China. Emerging Infectious Diseases, 26, 289-297. [Google Scholar] [CrossRef] [PubMed]
[22] Wu, Y., Wu, C., Bao, D., Jia, H., Draz, M.S., He, F., et al. (2022) Global Evolution and Geographic Diversity of Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae. The Lancet Infectious Diseases, 22, 761-762. [Google Scholar] [CrossRef] [PubMed]
[23] Russo, T.A., Lebreton, F. and McGann, P.T. (2025) A Step Forward in Hypervirulent Klebsiella pneumoniae Diagnostics. Emerging Infectious Diseases, 31, e1-e3. [Google Scholar] [CrossRef] [PubMed]
[24] Tang, Y., Du, P., Du, C., Yang, P., Shen, N., Russo, T.A., et al. (2025) Genomically Defined Hypervirulent Klebsiella pneumoniae Contributed to Early-Onset Increased Mortality. Nature Communications, 16, Article No. 2096. [Google Scholar] [CrossRef] [PubMed]
[25] Liao, W., Long, D., Huang, Q., Wei, D., Liu, X., Wan, L., et al. (2020) Rapid Detection to Differentiate Hypervirulent Klebsiella pneumoniae (HVKP) from Classical K. Pneumoniae by Identifying PEG-344 with Loop-Mediated Isothermal Amplication (LAMP). Frontiers in Microbiology, 11, Article 1189. [Google Scholar] [CrossRef] [PubMed]
[26] Bulger, J., MacDonald, U., Olson, R., Beanan, J. and Russo, T.A. (2017) Metabolite Transporter PEG344 Is Required for Full Virulence of Hypervirulent Klebsiella pneumoniae Strain hvKP1 after Pulmonary but Not Subcutaneous Challenge. Infection and Immunity, 85, e00093-17. [Google Scholar] [CrossRef] [PubMed]